BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35994404)

  • 21. Identification of Kaempferol as Viral Entry Inhibitor and DL-Arginine as Viral Replication Inhibitor from Selected Plants of Indian Traditional Medicine against COVID-19: An
    Jayaprakashkamath A; Murali M; Nair B; Benny F; Mani RP; Suresh D; Presanna AT; Areekkara AN; Nath LR
    Curr Comput Aided Drug Des; 2023; 19(4):313-323. PubMed ID: 36635906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion.
    Chen TH; Tsai MJ; Chang CS; Xu L; Fu YS; Weng CF
    J Infect Public Health; 2023 Jan; 16(1):42-54. PubMed ID: 36470006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico.
    Elfiky AA; Azzam EB; Shafaa MW
    Mol Divers; 2022 Feb; 26(1):171-181. PubMed ID: 33389441
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Patil SM; Martiz RM; Ramu R; Shirahatti PS; Prakash A; Chandra S J; Ranganatha VL
    J Biomol Struct Dyn; 2022; 40(23):13032-13048. PubMed ID: 34632942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an
    Ogunyemi OM; Gyebi GA; Elfiky AA; Afolabi SO; Ogunro OB; Adegunloye AP; Ibrahim IM
    Antivir Chem Chemother; 2020; 28():2040206620984076. PubMed ID: 33372806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
    Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment.
    Pauly I; Kumar Singh A; Kumar A; Singh Y; Thareja S; Kamal MA; Verma A; Kumar P
    Curr Pharm Des; 2022; 28(46):3677-3705. PubMed ID: 36345244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections.
    Jin YH; Min JS; Jeon S; Lee J; Kim S; Park T; Park D; Jang MS; Park CM; Song JH; Kim HR; Kwon S
    Phytomedicine; 2021 Jun; 86():153440. PubMed ID: 33376043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase.
    Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S
    Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
    Azeem M; Mustafa G; Mahrosh HS
    Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study.
    Rabie AM; Eltayb WA
    Mol Biotechnol; 2024 Apr; 66(4):592-611. PubMed ID: 36690820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
    Tsuji M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with synthetic/designer unnatural nucleoside analogs: an in silico study.
    Bag SS; Sinha S; Dutta S; Baishya HJ; Paul S
    J Mol Model; 2023 Nov; 29(12):366. PubMed ID: 37950101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
    Dhankhar P; Dalal V; Kumar V
    J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL
    Vincent S; Arokiyaraj S; Saravanan M; Dhanraj M
    Front Mol Biosci; 2020; 7():613401. PubMed ID: 33425994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.
    Zhang H; Yang Y; Li J; Wang M; Saravanan KM; Wei J; Tze-Yang Ng J; Tofazzal Hossain M; Liu M; Zhang H; Ren X; Pan Y; Peng Y; Shi Y; Wan X; Liu Y; Wei Y
    PLoS Comput Biol; 2020 Dec; 16(12):e1008489. PubMed ID: 33382685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2.
    Aljuaid A; Salam A; Almehmadi M; Baammi S; Alshabrmi FM; Allahyani M; Al-Zaydi KM; Izmirly AM; Almaghrabi S; Baothman BK; Shahab M
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies.
    Kumar Verma A; Kumar V; Singh S; Goswami BC; Camps I; Sekar A; Yoon S; Lee KW
    Biomed Pharmacother; 2021 May; 137():111356. PubMed ID: 33561649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19.
    Parihar A; Sonia ZF; Akter F; Ali MA; Hakim FT; Hossain MS
    Comput Biol Med; 2022 Jun; 145():105468. PubMed ID: 35390745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.